Unlike many people drawn to semaglutide, McCullar didn't have "food chatter" or binge-eating tendencies, but even after tracking her macros and working with a trainer, she was still struggling
That raises the prospect, she said, that patients will stop taking the drugs and regain weight, which will lead to poor clinical outcomes.
Clinical studies show that patients using semaglutide can lose 10-15% of their body weight over several months
Because adipose tissue produces estrogen, so a drop in body fat can temporarily reduce circulating estrogen levels
bioavailability has been estimated to be in the range of 1418 % for mixed diets and 512 % for vegetarian diets in individuals with no iron stores ( Reference Hurrell and Egli 65 )
(Reporting by Ludwig Burger, Editing by Miranda Murray) The GLP-1 drug class, which include Novo Nordisk's Wegovy and Eli Lilly's Zepbound, has enjoyed unprecedented demand in recent years, with some analysts projecting annual combined sales of $150 billion by the end of the decade
